GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotricity Inc (OTCPK:BTCY) » Definitions » Cyclically Adjusted Price-to-FCF

BTCY (Biotricity) Cyclically Adjusted Price-to-FCF : (As of Jul. 10, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Biotricity Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Biotricity Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Biotricity's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotricity Cyclically Adjusted Price-to-FCF Chart

Biotricity Annual Data
Trend Aug15 Dec16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Biotricity Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Biotricity's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Biotricity's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotricity's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotricity's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Biotricity's Cyclically Adjusted Price-to-FCF falls into.


;
;

Biotricity Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Biotricity's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Biotricity's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.011/133.1571*133.1571
=-0.011

Current CPI (Dec. 2024) = 133.1571.

Biotricity Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201411 -0.003 99.635 -0.004
201505 0.000 100.333 0.000
201508 -0.001 100.548 -0.001
201511 -0.011 100.135 -0.015
201603 0.000 100.470 0.000
201606 -0.138 101.688 -0.181
201609 -0.149 101.861 -0.195
201612 -0.135 101.863 -0.176
201703 -0.246 102.862 -0.318
201706 -0.280 103.349 -0.361
201709 -0.181 104.136 -0.231
201712 -0.200 104.011 -0.256
201803 -0.370 105.290 -0.468
201806 -0.227 106.317 -0.284
201809 -0.267 106.507 -0.334
201812 -0.247 105.998 -0.310
201903 -0.199 107.251 -0.247
201906 -0.225 108.070 -0.277
201909 -0.246 108.329 -0.302
201912 -0.351 108.420 -0.431
202003 -0.487 108.902 -0.595
202006 -0.391 108.767 -0.479
202009 -0.345 109.815 -0.418
202012 -0.479 109.897 -0.580
202103 -0.551 111.754 -0.657
202106 -0.411 114.631 -0.477
202109 -0.453 115.734 -0.521
202112 -0.548 117.630 -0.620
202203 -0.564 121.301 -0.619
202206 -0.471 125.017 -0.502
202209 -0.515 125.227 -0.548
202212 -0.366 125.222 -0.389
202303 -0.215 127.348 -0.225
202306 -0.209 128.729 -0.216
202309 -0.272 129.860 -0.279
202312 -0.145 129.419 -0.149
202403 -0.124 131.776 -0.125
202406 -0.105 132.554 -0.105
202409 -0.018 133.029 -0.018
202412 -0.011 133.157 -0.011

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biotricity  (OTCPK:BTCY) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Biotricity Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Biotricity's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotricity Business Description

Traded in Other Exchanges
N/A
Address
203 Redwood Shores Parkway, Suite 600, Redwood City, CA, USA, 94065
Biotricity Inc is a medical technology company that focuses on biometric data monitoring solutions. It aims to deliver remote monitoring solutions to the healthcare & consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. Biotricity is expanding medical-grade monitoring into the consumer market via its Biolife solution, which empowers users to self-manage chronic conditions. Its products include Bioflux, which is a mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of ambulatory patients' ECG information; Biocare Telemed; Bioheart, which is a personal heart monitor; Biokit, and Biocare health.
Executives
Chester P White director 447 BATTERY STREET, SUITE 230, SAN FRANCISCO CA 94111
Ronald W. Mcclurg director C/O NEUROONE MEDICAL TECHNOLOGIES CORP, 7599 ANAGRAM DR, EDEN PRAIRIE MN 55344
David A Rosa director 10901 RED CIRCLE DRIVE, SUITE 150, MINNETONKA MN 55343
Stephen Salmon director 1177 HAGEN ROAD, NAPA CA 94558
Patricia J Kennedy director 275 SHORELINE DRIVE, SUITE 150, REDWOOD CITY CA 94065
Norman M. Betts director 275 SHORELINE DRIVE, SUITE 150, REDWOOD CITY CA 94065
Waqaas Al-siddiq director, 10 percent owner, officer: CEO and Chairman of the Board C/O 275 SHORELINE DRIVE, SUITE 150, REDWOOD CITY CA 94065
John Ayanoglou officer: Chief Financial Officer C/O 275 SHORELINE DRIVE, SUITE 150, REDWOOD CITY CA 94065